OPNT - Opiant Pharmaceuticals' (OPNT) CEO Roger Crystal on Q4 2020 Results - Earnings Call Transcript

Opiant Pharmaceuticals, Inc. (OPNT) Q4 2020 Earnings Conference Call March 4, 2021 4:30 PM ET Company Participants Ben Atkins – Vice President-Investor Relations Roger Crystal – Chief Executive Officer David O'Toole – Chief Financial Officer Conference Call Participants Brandon Folkes – Cantor Fitzgerald Carl Byrnes – Northland Securities David Bautz – Zacks Presentation Operator Greetings. Welcome to the Opiant Pharmaceuticals Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Ben Atkins, Vice President of Investor Relations. You may begin. Ben Atkins Ben Atkins Thank you, operator, and thank you all for joining us this afternoon. With me on today's call, our Chief Executive Officer, Dr. Roger Crystal; and Chief Financial Officer, David O'Toole.

For further details see:

Opiant Pharmaceuticals' (OPNT) CEO Roger Crystal on Q4 2020 Results - Earnings Call Transcript